Jason Aligo

Director, Global Nonclinical Writing & Submissions, Johnson & Johnson Innovative Medicine @Johnson & Johnson Innovative Medicine

Wayne, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2026 — Present

Director, Global Nonclinical Writing & Submissions, Johnson & Johnson Innovative Medicine @Johnson & Johnson Innovative Medicine

View department →

Lead and mentor a global nonclinical writing team (internal + contractors).* Deliver nonclinical submission content (IB, IND/CTA/NDA modules, briefing books, HA responses).* Review and QC documents for standards, compliance, and clear risk messaging.* Evolve nonclinical submissions strategy to align with the global regulatory landscape.

EDUCATION

2002 — 2005

Penn State University

MS, Genetics, Virology, and Molecular Biology

1998 — 2002

University of Hartford

B.S., Biology

2005 — 2009

Penn State University

Ph.D., Genetics, Virology, Molecular Biology

ABOUT JASON ALIGO

People leader and senior research scientist with expertise in global nonclinical regulatory writing and submissions in pharmaceutical R&D. Director, Global Nonclinical Writing, leading a geographically distributed team delivering nonclinical documents for INDs, IBs, briefing books, and global regulatory interactions.15+ years of scientific experience spanning molecular pathology, immunotoxicology, virology, molecular/cell biology, and biochemistry. Continues to deepen expertise in global nonclinical writing and submission strategy in close partnership with cross functional teams.Focused, pragmatic leader in fast paced matrix environments, valued for organization, problem solving, and adaptability. Committed to mentoring talent and bringing clarity at the intersection of science, process, and regulatory strategy.Areas of expertise:· Global Nonclinical Writing & Submissions · Regulatory Documents (INDs, IBs, Briefing Books, Study Reports) · Molecular Pathology & Immunotoxicology · Virology, Molecular & Cell Biology, Biochemistry · Scientific Strategy & Data Integration · Assay Development (Preclinical/GLP‑like/non-GLP Environments) · Cross‑Functional Leadership & Mentoring · Process Optimization· Immune Surveillance & Translational Science · Electron & Fluorescence Microscopy · Immunohistochemistry / In Situ Hybridization · In Vitro & In Vivo Models

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jason Aligo — Director, Global Nonclinical Writing & Submissions, Johnson & Johnson Innovative Medicine at Johnson & Johnson Innovative Medicine in Wayne, PA, US | Unifers